معرفی
Dr. Vincent Chen is an Assistant Professor in the Department of Chemistry at Brandon University and Director of the Brandon University Proteomics Centre. His research focuses on proteomics, mass spectrometry, and their applications in understanding cancer biology, protein interactions, and drug development. He holds a BSc and PhD in Chemistry.
Key research areas include the molecular mechanisms of cancer resistance (e.g., glioblastoma and prostate cancer), proteomic profiling of secretomes and interactomes, and the development of novel therapeutic strategies targeting enzymes like IDH1 and MMP3. His work integrates advanced mass spectrometry techniques with systems biology approaches.
Dr. Chen’s lab (www.chenlab.ca) has published extensively on topics such as Temozolomide resistance in glioma cells, Cx43-mediated signaling pathways, and the role of ubiquitin ligases in protein regulation. Recent studies explore synergistic mechanisms of cancer metastasis and drug resistance using multidisciplinary proteomic methods.
No scientific awards were explicitly mentioned in the provided texts. His advising and grant activities are not detailed here, but his research aligns with significant contributions to clinical proteomics and cancer research. He leads the Brandon University Proteomics Centre, focusing on translational research at the interface of chemistry and oncology.
